Section Arrow
IQV.NYSE
- IQVIA Holdings
Quotes are at least 15-min delayed:2025/12/28 14:55 EST
Regular Hours
Last
 226.92
+0.9 (+0.40%)
Day High 
227.1125 
Prev. Close
226.02 
1-M High
232.71 
Volume 
426.07K 
Bid
225.95
Ask
227.7
Day Low
225.68 
Open
226.145 
1-M Low
214.01 
Market Cap 
38.49B 
Currency 美元 
P/E 31.09 
%Yield -- 
10-SMA 223.37 
20-SMA 224.61 
50-SMA 219.74 
52-W High 234.295 
52-W Low 134.645 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
7.27/9.87
Enterprise Value
51.50B
Balance Sheet
Book Value Per Share
36.17
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
15.41B
Operating Revenue Per Share
87.23
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OPKOPKO Health1.29-0.01-0.77%-- 
NEOGNeogen Corp7.13-0.01-0.14%879PE
PRPHProPhase Labs Inc.0.52-0.095-15.45%-- 
EXASExact Sciences Corp101.57+0.03+0.03%-- 
NEONeoGenomics12.28-0.02-0.16%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.